DANIELA KARANDA: Open Payments
NPI 1558730630 · HEBRON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$325 in 14 payments from 7 companies in 2025. Trend: 2023 $206 · 2024 $169 · 2025 $325
Food & beverage: $325
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $101 |
| ABBVIE INC. | 3 | $69 |
| PFIZER INC. | 2 | $56 |
| Ardelyx, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
Products named: Rybelsus, IBSRELA, VYNDAQEL, Auvelity, ELIQUIS, QULIPTA, Ozempic, VIBERZI.
Industry payments across CT — which companies pay providers there.
